These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23515063)

  • 21. Antimicrobial resistance: mechanisms and strategies.
    Woods CR
    Paediatr Respir Rev; 2006; 7 Suppl 1():S128-9. PubMed ID: 16798537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance and future of antimicrobial surveillance studies.
    Masterton R
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S21-31. PubMed ID: 18713046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009).
    Adriaenssens N; Coenen S; Versporten A; Muller A; Minalu G; Faes C; Vankerckhoven V; Aerts M; Hens N; Molenberghs G; Goossens H;
    J Antimicrob Chemother; 2011 Dec; 66 Suppl 6():vi47-56. PubMed ID: 22096066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Introduction: antibiotic resistance.
    Walsh C; Wright G
    Chem Rev; 2005 Feb; 105(2):391-4. PubMed ID: 15700949
    [No Abstract]   [Full Text] [Related]  

  • 25. [Is it still time to save the antibiotics?].
    Montravers P; Balcan I; Mascitti P
    Ann Fr Anesth Reanim; 2012 Sep; 31(9):675-6. PubMed ID: 22840927
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bacterial resistance in Germany. How great is the danger?].
    Kresken M
    Med Monatsschr Pharm; 2003 Feb; 26(2):38-44. PubMed ID: 12619522
    [No Abstract]   [Full Text] [Related]  

  • 27. A guide to antibiotic resistance in bacterial skin infections.
    Perera G; Hay R
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):531-45. PubMed ID: 16164705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mathematical model--tell us the future!
    Huovinen P
    J Antimicrob Chemother; 2005 Aug; 56(2):257-8; discussion 431. PubMed ID: 15972307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring of antimicrobial resistance among food animals: principles and limitations.
    Aarestrup FM
    J Vet Med B Infect Dis Vet Public Health; 2004; 51(8-9):380-8. PubMed ID: 15525370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editorial comment on: surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy.
    Novara G
    Eur Urol; 2008 Nov; 54(5):1175-6. PubMed ID: 18511181
    [No Abstract]   [Full Text] [Related]  

  • 31. Editorial comment on: surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy.
    Grabe M
    Eur Urol; 2008 Nov; 54(5):1176-7. PubMed ID: 18511182
    [No Abstract]   [Full Text] [Related]  

  • 32. Editorial comment on: surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy.
    Badalyan R
    Eur Urol; 2008 Nov; 54(5):1177-8. PubMed ID: 18511176
    [No Abstract]   [Full Text] [Related]  

  • 33. Stakeholder position paper: the need for antimicrobial use data for risk assessment.
    McEwen SA; Singer RS
    Prev Vet Med; 2006 Feb; 73(2-3):169-76. PubMed ID: 16266764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe.
    Ferech M; Coenen S; Malhotra-Kumar S; Dvorakova K; Hendrickx E; Suetens C; Goossens H;
    J Antimicrob Chemother; 2006 Aug; 58(2):401-7. PubMed ID: 16735414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009).
    Adriaenssens N; Coenen S; Versporten A; Muller A; Minalu G; Faes C; Vankerckhoven V; Aerts M; Hens N; Molenberghs G; Goossens H;
    J Antimicrob Chemother; 2011 Dec; 66 Suppl 6():vi37-45. PubMed ID: 22096065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (2003).
    Streit JM; Jones RN; Toleman MA; Stratchounski LS; Fritsche TR
    Int J Antimicrob Agents; 2006 May; 27(5):367-75. PubMed ID: 16647842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009).
    Versporten A; Coenen S; Adriaenssens N; Muller A; Minalu G; Faes C; Vankerckhoven V; Aerts M; Hens N; Molenberghs G; Goossens H;
    J Antimicrob Chemother; 2011 Dec; 66 Suppl 6():vi25-35. PubMed ID: 22096063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial drug consumption in companion animals.
    Heuer OE; Jensen VF; Hammerum AM
    Emerg Infect Dis; 2005 Feb; 11(2):344-5. PubMed ID: 15759339
    [No Abstract]   [Full Text] [Related]  

  • 39. [Bacterial resistance to antibiotics. Data from the National Observatory of Bacterial Resistance Epidemiology (ONERBA)].
    Conseil scientifique de l'ONERBA
    Med Mal Infect; 2005 Mar; 35(3):155-69. PubMed ID: 15911185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short summary of Swedres 2005, a report on Swedish antibiotic utilisation and resistance.
    Cars O; Olsson-Liljequist B; Lundh K
    Euro Surveill; 2007 Mar; 12(3):225. PubMed ID: 17439810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.